Lv22
118 积分 2025-10-26 加入
A Screening-Guided Biomimetic Exosome-Liposome Hybrid Nanoplatform Enables Pyroptosis-Enhanced Immune Reprogramming in Glioblastoma
7小时前
已完结
Enhanced Immunotherapy for Glioblastoma Using a Cholesterol Oxidase-Loaded, Pd-Doped Cu3N Nanozyme-Based Multimodal Nanoplatform
7小时前
已完结
MMP-2-triggered, mitochondria-targeted PROTAC-PDT therapy of breast cancer and brain metastases inhibition
3天前
已完结
Enhanced Antiglioma Effect by a Vitamin D3-Inserted Lipid Hybrid Neutrophil Membrane Biomimetic Multimodal Nanoplatform
3天前
已完结
NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
5天前
已完结
First PROTAC gains FDA approval, bolstering targeted protein degradation and induced proximity ambitions
5天前
已完结
Development of miRNA-based PROTACs targeting Lin28 for breast cancer therapy
5天前
已完结
Optimization of preparation methods for high loading content and high encapsulation efficiency of BSH into liposomes
6天前
已完结
Time-staggered chemo-immunotherapy via engineered nanofiber resists postoperative dynamic immunosuppression in glioblastoma
10天前
已完结
皖公网安备34019202002308
